Business · 04/12/2012Updated: 10/17/2026 · 1 min read
FDA Releases Guidance on Investigational New Drug Applications for PET Drugs
Summary
The Food and Drug Administration (FDA) has released a guidance document to help manufacturers of Positron Emission Tomography (PET) drugs prepare and submit Investigational New Drug Applications (INDs).
Original source language: Federal Register — Food and Drug AdministrationOpen original release →